Study to evaluate the effect of ticagrelor versus placebo in reducing Vaso-Occlusive Crises rate in pediatric patients with Sickle Cell Disease.

Trial Identifier:	D5136C00013
Sponsor:	AstraZeneca
Collaborator:	IQVIA
NCTID::	NCT04293172
Start Date:	June 2020
Primary Completion Date:	October 2022
Study Completion Date:	October 2022
Condition:	Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.